StriderDCT Signs MoU with Artificial Brain for Developing Quantum-Powered AI Solutions For Clinical Research
StriderDCT is pleased to share that it has signed a Memorandum of Understanding (MoU) with Artificial Brain to jointly develop Quantum-Powered AI solutions for Clinical Research. StriderDCT brings deep domain expertise in decentralized and technology-enabled clinical trials, with a strong




